Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Part I – Neurobiology of ketamine effects
- Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission
- Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
- The role of eEF2 kinase in the rapid antidepressant actions of ketamine
- Clinical overview of NMDA-R antagonists and clinical practice
- Ketamine for depression clinical issues
- Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence
- Neurobiological biomarkers of response to ketamine
- Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants
- The emergence of ketamine as a novel treatment for posttraumatic stress disorder
- mGlu2/3 receptor as a novel target for rapid acting antidepressants
- Involvement of muscarinic receptor mechanisms in antidepressant drug action
- The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions
Allie J. Widman and Lori L. McMahon
Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson
Kanzo Suzuki and Lisa M. Monteggia
Part II – The rapid therapeutic effects of ketamine
Pasha A. Davoudian and Samuel T. Wilkinson
Syed Z. Iqbal and Sanjay J. Mathew
Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah
Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr
Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets
Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney
Part III – Novel rapid-acting antidepressant mechanisms related to ketamine
Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin
Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey
The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine
- No. of pages:
- © Academic Press 2020
- 26th June 2020
- Academic Press
- Hardcover ISBN:
- eBook ISBN:
Ronald Duman is at Yale University School of Medicine, CT, USA
Yale University School of Medicine, CT, USA
John Krystal is at Yale University, CT, USA
Yale University, CT, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.